Marco Bernocchi

Corporate Planning & Controlling Director - Special Projects @MENARINI Group

With a turnover of 4.0 billion EURO, Menarini is the leading Italian Pharmaceutical Group ranking 32th in the world and 17th in Europe. Menarini is also among the largest 100 European companies in all sectors. The Group has more than 17,500 employees of whom 80% are employed abroad and the remaining 20% in Italy.\\\\n\\\\nMenarini has always pursued two strategic objectives: research and internationalisation, the Group is now present in more than 130 countries worldwide through affiliates, distributors or licensees operating in the most important therapeutic areas including cardiovascular, gastroenterology, oncology, antibiotics, respiratory, diabetology and anti-inflammatory agents-analgesics.\\\\n\\\\nAs Corporate Planning & Controlling Director - Special Projects I am part of all the \"Project Teams\" that are in charge to manage important, complex and strategic projects across the Group such as, for example, the construction of the new manufacturing plant in Florence with an estimated investment of 150 Millions Euro.\\\\nBy relying upon the assistance of all the relevant departments I am responsible for the management of all the aspects of each single project related to finance, financial planning, controlling, costs management, fiscal issues, funding, etc.\\\\n\\\\nOther assignments and / or responsibilities:\\\\nPresident of the Board of Istituto Luso Farmaco d\' Italia S.p.A.\\\\nMember of the Board of A. Menarini Procurement S.r.L.\\\\nMember of the Board of Malesci Istituto Farmacobiologico S.p.A.\\\\nMember of the Board of A. Menarini Diagnostics S.r.L.\\\\n \\\\n\\\\n \\\\n \\\\n\\\\n \\\\n